Keywords: gsk, 2nd-qtr, eps, drops, uk, drugmaker, glaxosmithkline
GSK's 2nd-qtr 2004 EPS drops 12%
Article | 02 August 2004
UK drugmaker GlaxoSmithKline is continuing its rough ride through 2004,having posted a 12% drop in second-quarter earnings to 20.1 pence a share ( ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- Novo Nordisk's diabetes drug Victoza produced 8% weight loss in Ph III obesity trial
- Is the diabetes market facing a blockbuster-free future?
- Alchemia and Merck Serono collaborate on HA-Irinotecan with Erbitux
- Positive new data on Novartis' Galvus in elderly type 2 diabetes patients
- Johnson & Johnson expects 10 NDA filings by 2017, saying pharma sector poised for growth
